Sign in
Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Surgical Implantation of a Biosynthetic RPE Monolayer for Advanced Dry Age-Related Macular Degeneration (AMD): Experience From a Phase 1/2A Study
Amir H Kashani, MD PhD
Annual Meeting Talks
2019
Episode 155: Argus II Quality of Life Improvements and More with Dr. Jacque Duncan
Jayanth Sridhar, MD
Member Podcasts
2018
Category: AMD-Non-Neovascular